Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0012
0.00 (0.00%)
Aug 1, 2025, 2:14 PM EDT
CTI BioPharma Market Cap
Syros Pharmaceuticals has a market cap or net worth of $42.93 thousand as of August 1, 2025. Its market cap has decreased by -99.98% in one year.
Market Cap
42.93K
Enterprise Value
1.99M
Revenue
386.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from 413.10M to 42.93K, a decrease of -99.99%. That is a compound annual growth rate of -63.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 42.93K | -99.30% |
| Dec 31, 2024 | 6.17M | -96.96% |
| Dec 29, 2023 | 202.59M | 179.01% |
| Dec 30, 2022 | 72.61M | -64.04% |
| Dec 31, 2021 | 201.95M | -59.37% |
| Dec 31, 2020 | 497.05M | 69.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 351.67M |
| CytoDyn | 341.59M |